Printer Friendly
The Free Library
19,607,053 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cortech, Inc. Reports Financial Results.


BEDMINSTER Bedminster may refer to:
  • Bedminster, Bristol, United Kingdom
  • Bedminster Down, Bristol, United Kingdom
  • Bedminster Township, New Jersey, United States
  • Bedminster Township, Pennsylvania, United States
, N.J.--(BUSINESS WIRE)--

CORTECH, INC inc - /ink/ increment, i.e. increase by one. Especially used by assembly programmers, as many assembly languages have an "inc" mnemonic.

Antonym: dec.
. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:CRTQ) reported net income for the three months ended June June: see month.  30, 1999 of $1,842,000, or $.99 per share, compared to a net loss of $1,431,000, or $.77 per share, for the comparable period in 1998. For the six months ended June 30, 1999, net income was $2,042,000, or $1.10 per share, compared to a net loss of $2,830,000, or $1.53 per share, for the comparable period in the prior year. Net income for the three and six months ended June 30, 1999 includes a non-recurring license fee of $2,000,000 received in connection with an agreement with Ono Ono (ō`nō), in the Bible, town, W central ancient Palestine, the modern Qiryat Ono, Israel, E of Tel Aviv.  Pharmaceutical Co., Ltd of Osaka Osaka (ō`säkä), city (1990 pop. 2,623,801), capital of Osaka prefecture, S Honshu, Japan, on Osaka Bay, at the mouth of the Yodo River. , Japan, to license the worldwide rights to an oral elastase elastase /elas·tase/ (e-las´tas) see pancreatic elastase.

e·las·tase
n.
An enzyme found especially in pancreatic juice that catalyzes the hydrolysis of elastin.
 inhibitor inhibitor /in·hib·i·tor/ (in-hib´i-tor)
1. any substance that interferes with a chemical reaction, growth, or other biologic activity.

2.
 program. Per share information referred to in this news release is both basic and diluted earnings per share diluted earnings per share

An earnings measure calculated by dividing net income less preferred stock dividends for a period by the average number of shares of common stock that would be outstanding if all convertible securities were converted into shares of
. Cortech has 1,852,209 shares outstanding.

This release contains forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 which may involve known and unknown risks, uncertainties and other factors that may cause Cortech's actual results and performance in future periods to be materially different from any future results or performance suggested by these statements. Cortech cautions investors not to place undue reliance on forward-looking statements, which speak only to management's expectations on this date. -0-

                             CORTECH, INC.
                           OPERATING RESULTS
       FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 1999 AND 1998
                 (in thousands, except per share data)
                              (Unaudited)

                                Three Months Ended   Six Months Ended
                                     June 30,            June 30,
                                  --------------      --------------
                                  1999      1998      1999      1998
                                  ----      ----      ----      ----

Revenues:

 Interest income                $   127   $   183   $   251   $   379
 Gain on disposition of
   property and equipment            64        12       310       228
 Non-recurring license fee        2,000        --     2,000        --
 Other income                        15        22        60        22
                                -------   -------   -------   -------
  Total revenues                  2,206       217     2,621       629
                                -------   -------   -------   -------

Expenses:

 General and administrative         146     1,498       361     3,023
 Research and development            --       150        --       436
                                -------   -------   -------   -------
  Total expenses                    146     1,648       361     3,459
                                -------   -------   -------   -------

Income (loss) before income
  taxes                           2,060    (1,431)    2,260    (2,830)
Provision for income taxes          218        --       218        --
                                -------   -------   -------   -------
Net income (loss)               $ 1,842   ($1,431)  $ 2,042   ($2,830)
                                =======   =======   =======   =======

Basic and diluted net income
  (loss) per common share       $   .99   ($  .77)  $  1.10   ($ 1.53)
                                =======   =======   =======   =======

Weighted average number of
  common shares outstanding
  (in 000's)                      1,852     1,852     1,852     1,852
                                =======   =======   =======   =======


                        CONDENSED BALANCE SHEET
                             June 30, 1999
                            (in thousands)
                              (Unaudited)

Cash and cash equivalents                                     $13,359
Prepaid expenses and other                                          5
                                                              -------
 Total assets                                                 $13,364
                                                              =======

Liabilities                                                   $   781
Stockholders' equity                                           12,583
                                                              -------
 Total liability and stockholders' equity                     $13,364
                                                              =======
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Aug 13, 1999
Words:418
Previous Article:Oakwood Homes On Fitch IBCA RatingAlert Negative.
Next Article:Motorola Comments On Iridium LLC Developments.
Topics:



Related Articles
Cortech Announces Election of New Officers; Implementation of Reverse Stock Split and Elimination of Shareholder Rights Plan.
Cortech Makes Announcement.
Cortech Makes Announcement.
Cortech Reports Three and Nine Months Results.
CORTECH Announces Third Quarter Results.
Cortech Compound May Provide AIDS Treatment Advance.
Cortech Announces Second Quarter Results.
Cortech Announces Third Quarter Results.
FIRM'S FISCAL REPORT ANYTHING BUT GOLDEN.
Software checks profile die designs. (Extrusion).

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles